 "Serum Institute of India")
BENGALURU (Reuters) - Serum Institute of India, the world's largest vaccine maker by production volume, has taken a 50% stake in Indian drug vial maker Schott Kaisha, the companies said in a statement https://bit.ly/3AIBLvS on Tuesday.
Serum Institute was already a customer of Schott Kaisha, using their vials, ampoules and syringes to store vaccines including the COVID-19 vaccine Covishield. The companies did not provide any further details on the deal.
(Reporting by Anuron Kumar Mitra in Bengaluru; Editing by Bernard Orr)
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
